Gainers
- Nuwellis NUWE stock rose 46.8% to $0.48 during Monday's after-market session. The company's market cap stands at $3.2 million.
- Sensei Biotherapeutics SNSE stock rose 7.42% to $1.0. The market value of their outstanding shares is at $25.0 million.
- Cognition Therapeutics CGTX stock increased by 6.98% to $1.99. The company's market cap stands at $77.6 million.
- Allarity Therapeutics ALLR shares increased by 5.63% to $1.5. The company's market cap stands at $2.9 million.
- Purple Biotech PPBT shares moved upwards by 4.98% to $0.48. The company's market cap stands at $12.3 million.
- Mereo BioPharma Group MREO stock moved upwards by 4.65% to $2.92. The company's market cap stands at $409.5 million.
Losers
- Phio Pharma PHIO shares declined by 7.8% to $0.76 during Monday's after-market session. The market value of their outstanding shares is at $3.5 million.
- OptiNose OPTN shares fell 7.09% to $0.96. The market value of their outstanding shares is at $107.8 million.
- Portage Biotech PRTG stock fell 7.04% to $0.28. The market value of their outstanding shares is at $5.5 million.
- Cara Therapeutics CARA shares declined by 6.86% to $0.68. The market value of their outstanding shares is at $37.1 million.
- Rigel Pharmaceuticals RIGL shares fell 6.2% to $1.06. The company's market cap stands at $185.9 million.
- Greenwich LifeSciences GLSI stock decreased by 5.44% to $12.0. The company's market cap stands at $154.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CARACara Therapeutics Inc
$0.4450-2.71%
CGTXCognition Therapeutics Inc
$0.65005.86%
GLSIGreenwich LifeSciences Inc
$12.351.56%
MREOMereo BioPharma Group PLC
$3.7410.3%
NUWENuwellis Inc
$1.114.72%
OPTNOptiNose Inc
$0.3922-6.26%
PHIOPhio Pharmaceuticals Corp
$2.07-7.17%
PPBTPurple Biotech Ltd
$3.895.13%
PRTGPortage Biotech Inc
$4.94-8.35%
RIGLRigel Pharmaceuticals Inc
$16.43-4.20%
SNSESensei Biotherapeutics Inc
$0.4507-0.29%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in